Fluidigm Corp. (FLDM) Rating Reiterated by Cantor Fitzgerald
Fluidigm Corp. (NASDAQ:FLDM)‘s stock had its “buy” rating reaffirmed by Cantor Fitzgerald in a research note issued on Saturday. They currently have a $9.00 price objective on the stock, down from their previous price objective of $11.00. Cantor Fitzgerald’s price objective suggests a potential upside of 101.34% from the company’s previous close.
Several other equities research analysts have also recently commented on FLDM. Zacks Investment Research raised Fluidigm Corp. from a “hold” rating to a “buy” rating and set a $10.00 price target for the company in a research note on Tuesday, July 5th. Mizuho boosted their price target on Fluidigm Corp. from $11.00 to $12.00 and gave the company a “buy” rating in a research note on Friday, August 5th. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $13.48.
Shares of Fluidigm Corp. (NASDAQ:FLDM) opened at 4.47 on Friday. The firm’s market cap is $129.79 million. Fluidigm Corp. has a 52-week low of $4.41 and a 52-week high of $12.09. The stock’s 50 day moving average is $8.12 and its 200-day moving average is $9.11.
Fluidigm Corp. (NASDAQ:FLDM) last announced its quarterly earnings results on Thursday, August 4th. The company reported ($0.64) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.58) by $0.06. The firm earned $28.20 million during the quarter, compared to the consensus estimate of $29.62 million. Fluidigm Corp. had a negative net margin of 52.04% and a negative return on equity of 45.68%. The company’s quarterly revenue was down 1.5% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.53) EPS. Equities analysts anticipate that Fluidigm Corp. will post ($2.32) earnings per share for the current fiscal year.
Hedge funds and other institutional investors have recently modified their holdings of the company. Cookson Peirce & Co. Inc. acquired a new position in shares of Fluidigm Corp. during the second quarter worth approximately $123,000. BlackRock Advisors LLC raised its position in shares of Fluidigm Corp. by 10.4% in the second quarter. BlackRock Advisors LLC now owns 14,529 shares of the company’s stock worth $131,000 after buying an additional 1,373 shares during the period. Parametric Portfolio Associates LLC raised its position in shares of Fluidigm Corp. by 89.3% in the second quarter. Parametric Portfolio Associates LLC now owns 21,070 shares of the company’s stock worth $190,000 after buying an additional 9,939 shares during the period. Stoneridge Investment Partners LLC acquired a new position in shares of Fluidigm Corp. during the second quarter worth approximately $220,000. Finally, AQR Capital Management LLC raised its position in shares of Fluidigm Corp. by 58.8% in the second quarter. AQR Capital Management LLC now owns 25,187 shares of the company’s stock worth $227,000 after buying an additional 9,324 shares during the period. Institutional investors own 93.33% of the company’s stock.
Fluidigm Corp. Company Profile
Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.
Receive News & Ratings for Fluidigm Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Corp. and related companies with MarketBeat.com's FREE daily email newsletter.